ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2083

Environmental Factors Associated With Disease Flare In Juvenile and Adult Dermatomyositis

Gulnara Mamyrova1, Lisa G. Rider2, Olcay Jones3, Alison Ehrlich4, Lauren M. Pachman5, Robert Nickeson6, Lisa G. Criscione-Schreiber7, Frederick W. Miller2, Lawrence K. Jung8 and James D. Katz1, 1Rheumatology, George Washington University, Washington, DC, 2Environmental Autoimmunity Group, NIEHS, NIH, Bethesda, MD, 3Pediatrics, Walter Reed National Military Medical Center, Bethesda, MD, 4Dermatology, The George Washington University, Washington, DC, 5Division of Pediatric Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 6Pediatrics, All Children's Hospital, St Petersburg, FL, 7Dept of Med/Rheum Div, Duke University School of Medicine, Durham, NC, 8Pediatric Rheumatology, Children's National Medical Center, Washington, DC

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: dermatomyositis, Disease Activity, environmental factors and juvenile dermatomyositis

  • Tweet
  • Email
  • Print
Session Information

Title: Muscle Biology, Myositis and Myopathies: Advances in the Epidemiology, Immunology and Therapy of Myositis

Session Type: Abstract Submissions (ACR)

Background/Purpose: To assess environmental factors in relationship to increased disease activity (flare) in juvenile and adult dermatomyositis (DM).

Methods: An online survey was conducted for juvenile and adult DM patients from the US and Canada who were ≥1 year from diagnosis. Patients were recruited through myositis clinics and by a patient support group. The survey examined: exposures during the 6 months prior to disease flare, if the patient experienced a flare within the past 2 years, or in the past 6 months, if the patient did not have a flare. Exposures assessed included smoking, sun exposure, infections, medications, vaccines, stressful life events, and sport activities. Differences were evaluated by Chi-square and Fisher’s exact tests.

Results: Of 210 participants meeting probable or definite Bohan and Peter criteria (164 juvenile and 46 adult DM patients), 134 (63.8%) (103 juvenile and 31 adult DM) experienced a flare and 76 (36.2%) (61 juvenile and 15 adult DM) participants did not experience a disease flare within the past 2 years. For those reporting a disease flare, the mean duration to flare was 13 months for JDM and 10 months for DM. Eighty percent of patients with a flare were female vs. 70% of those without flare; 85% were Caucasian. Patients with flare were less often 0-5 years of age compared to those who did not flare (2.2% vs. 15.8%, p=0.0004). Patients with a disease flare more often reported that their myositis worsened after sun exposure (44.4% vs. 28.6%, p=0.03, OR=1.99, 95% CI: 1.1-3.7), but the use of photoprotective measures was similar between both groups. Infections were more frequently recorded in the preceding 6 months in those who flared vs. those who did not, including UTI (10.2% vs. 0.0%, p= 0.005, OR=16.4, CI: 0.96-280.2) and gastroenteritis (16.5% vs. 5.8%, p=0.04, OR=3.2, CI: 1.1-9.8). Patients who flared more frequently used NSAIDs (63.4% vs. 36.8%; p=0.0003, OR=3.0, CI: 1.7-5.3) or blood pressure medicines (12.7% vs. 3.9%, p=0.049, OR=3.5, CI: 1.0-12.5). HPV vaccine was more frequent in those who flared vs. those who did not (8.2% vs. 0.0%, p=0.032, OR=10.0, CI: 0.6-175.5).  Patients who flared tended to experience more frequent serious financial difficulties compared to those who did not (17.2% vs. 7.9%, p=0.06, OR=2.4, CI: 0.9-6.2), but other stressful life events did not differ. Patients with a flare more often exercised 1-5 times a week (74.7% vs. 57.7%, p=0.06, OR=2.2, CI: 1.02-4.6). There was no difference in smoking exposure between the two groups.

Conclusion: Sun exposure, certain infections, medications, and vaccines, which have been associated with illness onset, may also play a role in disease flares in patients with adult and juvenile DM.


Disclosure:

G. Mamyrova,

CureJM,

2;

L. G. Rider,
None;

O. Jones,
None;

A. Ehrlich,
None;

L. M. Pachman,
None;

R. Nickeson,
None;

L. G. Criscione-Schreiber,
None;

F. W. Miller,
None;

L. K. Jung,
None;

J. D. Katz,

CureJM,

2.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/environmental-factors-associated-with-disease-flare-in-juvenile-and-adult-dermatomyositis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology